Covaxin Phase 1 Trial Clears Lancet Review - The Sikh Times
Politics

Covaxin Phase 1 Trial Clears Lancet Review

New Delhi: 22 Jan 21 Covaxin, India’s first indigenous vaccine against COVID-19, showed enhanced immune response without any serious side effects in the Phase 1 trials, according to the results published in well-respected Lancet Infectious Disease journal on Friday.Similar peer-reviewed studies for the Phase 2 are still awaited and Phase 3 trials are ongoing even as the government continues to give out the jabs to lakhs of front-line workers. While the first two phases of vaccine trials usually focus on their safety, the third stage generally determines its efficacy.

Related posts

Arvind Kejriwal On AAP’s First Ever Win In Goa

thesikh

“Goli Maaro…”: 3 BJP Workers Arrested In Bengal

thesikh

Tejashwi Yadav Can Lead When Older: Uma Bharti

thesikh

PM Replies On Motion Of Thanks To President’s Address In Rajya Sabha

thesikh

Former prime minister Atal Bihari Vajpayee’s birth anniversary on December 25

thesikh

BJP Slams AAP Over Withdrawal Of Buses Hired For Police Personnel’s Movement

thesikh

Leave a Comment